In a 13G filing on Celldex Therapeutics (NASDAQ: CLDX), Steven Cohen's hedge fund SAC Capital disclosed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE